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ABSTRACT
Development of a Synthetic Route to Aminofluorohexenones as Precursors for
Novel Caspase Inhibitors
by
Ping Xi
Dr. Lydia McKinstry, Examination Committee Chair 
Assistant Professor of Chemistry 
University of Nevada, Las Vegas
Apoptosis is a normal biological process in which cells commit suicide. In cancer 
cells, a family of proteases called caspases, is involved in one or more of the signaling 
pathways leading to apoptosis. To better understand this cellular mechanism at the 
molecular level, selective inhibition of each caspase would allow scientists to determine 
the exact function of that caspase in the overall pathway. The long term goal of this 
research project is the synthesis of new, highly specific caspase inhibitors that will be 
used to study the mechanism of apoptosis in certain cancer cells. The first step, and the 
primary focus of this thesis, is successful development of a synthetic route to a group of 
aminofluorohexenone precursor molecules. The strategy for synthesizing these subtargets 
first involves investigation of a method for carbon-carbon bond formation adjacent to 
nitrogen, that focuses on an electrophilic substitution reaction based on charge affinity 
inversion of customary amine reactivity. The second part o f the synthetic strategy 
involves generation of pentenoic acid analogs to be used as electrophiles in the overall 
construction of the caspase inhibitor aminofluorohexenone precursors.
m
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CHAPTER 1
INTRODUCTION
1.1 Introduction
Proteolytic enzymes activate and regulate numerous cellular processes and are 
essential for normal biological function. In many abnormal processes such as the growth, 
death and migration of cancer cells, the specific roles of certain protease enzymes are not 
known. For instance, all cells (normal and cancerous) are known to undergo a process of 
cell suicide called apoptosis.' In cancer cells, a family of pro teases called caspases, is 
involved in one or more of the signaling pathways leading to apoptosis.^ To better 
understand this important mechanism at the molecular level, selective inhibition of each 
caspase would allow scientists to determine the exact function of that caspase in the 
overall pathway leading to apoptosis.
The long term goal of this research project is the synthesis of new, highly specific 
caspase inhibitors that will be used to study the mechanism of apoptosis in certain cancer 
cells. The strength, or effectiveness, of a molecule for inhibiting a certain enzyme’s 
activity is determined by how specifically the inhibitor interacts with that enzyme and 
how well the inhibitor mimics catalytic intermediates. The first property is known as 
inhibitor specificity. For protease inhibitors, specificity is determined by charged 
interactions over an extended region within the active site. One current strategy for 
improving inhibitor strength involves changing the molecular structure of the natural
1
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enzyme substrate (e.g. a peptide) in order to optimize the inhibitor-enzyme binding 
interactions. These compounds are known as peptide based inhibitors and their binding 
domain can be defined as a single site or as an extended region on either side of the 
amide bond cleavage site. Several commercial peptide-based inhibitors are known but 
have limitations in terms of their specificity for caspases. Many of them only interact 
with the enzyme on one side of the cleavage site, reducing their specificity and potency.^ 
The second property determining inhibitor strength involves the mechanism by which 
the enzyme catalyzes the breakdown of a peptide substrate. Within the enzyme active 
site, a peptide bond is hydrolyzed and the substrate is cleaved into two pieces. In natural 
peptide hydrolysis, a catalytic intermediate called a tetrahedral intermediate is formed at 
the cleavage site."' Since peptide-based inhibitors are designed to undergo the same 
mechanism, increasing the lifetime of this intermediate (i.e. stabilization) leads to 
increased inhibitor potency. Studies have shown that fluorinated inhibitors can stabilize a 
tetrahedral intermediate and increase the lifetime of an enzyme-inhibitor complex.^ 
Therefore, incorporation of fluorine into a peptide-based inhibitor molecule will result in 
more potent inhibitors.
1.2 Project Overview 
The ultimate goal of this research project is the synthesis of new, highly specific 
caspase inhibitors that will be used to study the mechanism of apoptosis in certain cancer 
cells. As described in the following chapter and summarized in Figure 1.1, the proposed 
new inhibitor molecules are designed to allow for increased charged interactions 
throughout the entire active site by introducing functional groups on the Pn’ side
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
(towards the C-terminus). Increased stabilization of a tetrahedral enzyme-inhibitor 
intermediate will also be achieved through incorporation of fluorine.
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Figure 1.1 Relationship between the proposed inhibitors (b) and the natural substrate (a)
The complete synthesis of a first generation of caspase inhibitors requires two major 
steps. The first step, and the primary focus of this thesis, is successful development of a 
synthetic route to aminohexenone subtarget molecules 2a -c as shown in Figure 1.2.
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AA —  AA — AA
N-terminus 
AA = amino acid
AA
1
Subtarget 2a-c 
a: Z=H, Y=F
HgN
R
Aa ] — [ AA 
C-terminus
X=CI, OR, NR2 (H) 
3a-c
b: Z=H, Y=CH3 c : Z=F, Y=CH3
Figure 1.2 Retrosynthetic scheme for peptide-based inhibitors 1 from 2-fluoro-, 
2-methyl- and 2-fluoro-2-methyl-4-pentenoyl precursors 3a - c
The strategy for synthesizing subtarget 2 first involves an investigation of methods for 
carbon-carbon bond formation adjacent to nitrogen. If successful, this method will find 
widespread application in the synthesis of a variety of amine natural products. The 
second step, also depicted retrosynthetically in Figure 1.2, will involve oxidation of 
subtarget 2 and amino acid coupling, to yield the first generation of new inhibitor 
molecules.
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CHAPTER 2
BACKGROUND
2.1 Proteases, Caspases and Apoptosis 
Proteases - Enzymes are protein molecules that speed up chemical reactions in all 
plants and animals. These molecules regulate numerous biological processes either 
directly or indirectly by acting on other enzymes. Without enzymes, many biological 
reactions would occur too slowly or not at all, and no life would be possible. Sometimes 
however, metabolic disorders are caused by abnormal enzyme function. Proteolytic 
enzymes or proteases, are defined as enzymes which break down proteins by cleaving 
peptide (amide) bonds. Proteases are classified into four categories according to the 
distinct functional groups within the enzyme active site: 1) Serine proteases (hydroxyl, 
imidazole and carboxyl groups), 2) Cysteine proteases (thiol, imidazole and carboxyl 
groups), 3) Aspartyl proteases (carboxyl groups), and 4) Metalloproteases (metal ion, 
often a zinc ion).'
Capases - Caspases are one family of cysteine proteases which have enzymatic 
specificity for cleaving peptide bonds at aspartic acid (Asp or D) residues.^’̂  We are 
interested in caspases because of the role they play in the process of apoptosis or 
programmed cell death. For caspases and all cysteine proteases, the catalytic mechanism 
involves initial nucleophilic attack by a cysteine thiol group on a peptide amide bond, to 
form a tetrahedral intermediate (Figure 2.1).'
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Figure 2.1 Catalytic mechanism of cysteine proteases
A histidine bound imidazole group activates the thiol group prior to nucleophilic addition 
by serving as a Bronsted-Lowry base. Stabilization of the tetrahedral intermediate occurs 
by hydrogen-bond interactions between the anionic oxygen and amide hydrogens within 
the active site. Decomposition of the tetrahedral intermediate, assisted by proton transfer 
from the imidazole, results in an acyl-enzyme intermediate and the free amine product. 
Subsequent hydrolysis of the acyl-enzyme intermediate, via a second tetrahedral 
intermediate, releases the acid component o f the substrate.
Like many proteases, caspases are formed as proenzymes (a.k.a. zymogens) which 
are inactive forms of the enzyme. Activation occurs when a portion of the proenzyme is
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
cleaved, usually by another protease. For caspases, usually another caspase will cleave 
the zymogen in specific regions, leading to the activated enzyme.^'^’̂ ''° Once activated, 
the caspase will then carry out its function in the mechanism of programmed cell death.
At least 15 different caspases have been identified as being associated with the 
process of apoptosis.^’̂ ’̂  All of these caspases have a preference for cleaving peptides at 
aspartic acid (D) residues, which are part of a four amino acid specifictity site or 
recognition motif (specificity will be discussed in more detail in Section 2.2).^ Initiator 
caspases and effector caspases are the two general categories of caspases involved with 
apoptosis.^’̂ ’* Initiator caspases are associated with the early stages of apoptosis and 
preferentially cleave at specificity sites of the general form A depicted in 
Figure 2.2(a).^'^’̂
(a): A: N-terminus 
N-terminus 
N-terminus
(b): B: N-terminus
I - 
L
V
D
E - -  X — -  D ——  C-terminus
E - -  X —-  D - C-terminus
E - -  X —-  D - —  C-terminus
-----  cleavage site
E - -  X —-  D - —  C-terminus
I = isoleucine, L = leucine, V = valine, E = glutamic acid, D = aspartic acid, 
X = any amino acid residue
Figure 2.2 Recognition motifs for (a) initiator caspases and (b) effector caspases
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Effector caspases are associated with later stages of apoptosis such as cell disassembly 
and preferentially cleave at specificity sites of the general form B depicted in Figure
Apoptosis - Apoptosis is a normal biological process first described by Kerr, Wyllie 
and Currie, in which cells commit suicide." Apoptosis is fundamental to regulating cell 
growth and tissue development.^ It is a genetically programmed process designed to 
rapidly eliminate unwanted cells and can be triggered by either intracellular or 
extracellular factors. In contrast, certain metabolic diseases such as cancer and AIDS are 
often associated with abnormal enzyme function and / or unregulated apoptosis."^ Since 
one approach to disease treatment could involve controlling the process o f apoptosis in 
unwanted cells, scientists must understand the details of the apoptotic pathway(s). We are 
interested in determining the specific roles of caspase enzymes in the regulation of 
apoptosis.
Several reports conclude that there are two general pathways for apoptosis (see Figure
2.3 below).^’̂ ’'^’'  ̂ One mechanism, known as the receptor mediated pathway is triggered 
by the binding of specific ligand molecules to cell surface receptors." Ligand binding 
results in transmission of a chemical signal into the cell cytoplasm which results in 
cleavage or activation of procaspase-8 to caspase-8 (an initiator caspase).^’'^’'^ Activation 
of caspase-10 is also believed to occur at this stage.^’’̂ ’'  ̂Procaspase-3 is the substrate for 
caspase-8 and therefore caspase-3 activation occurs next in the sequence.'^ Caspase-3 is 
an effector caspase and is the point o f convergence for both apoptotic pathways.^
The second apoptotic mechanism is initiated by signals within the cell and is called 
the intrinsic or mitochondrial pathway (see Figure 2.3 b e l o w ) . I n  this mechanism.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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Figure 2.3 Two general pathways of apoptosis
intracellular signals cause the mitochondria to release certain molecules into the 
cytoplasm resulting in the formation of an apoptosome complex.^'^'’̂ '̂̂  ̂ This complex 
contains procaspase-9 which becomes activated to caspase-9 by the apoptosome.^’̂ '®’'^’'"*
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Caspase-9 (an initiator caspase) then activates caspase-3 by cleaving the procaspase-3 
zymogen and the two apoptotic pathways converge.^’̂ ’'"' In either case, procaspase-7 is 
the substrate for caspase-3 (an effector caspase) and once activated, caspase-7 targets 
substrates within the cell nucleus leading to degradation of chromosomal DNA, digestion 
of structural proteins in the cytoplasm and ultimately cell death.^
Although caspase-3 has been identified as a key mediator of apoptosis in mammalian 
cells, the function of all caspases (e.g. caspase-10, -6, and -4) and the mechanism of 
programmed cell death is not completely understood.^^ By selectively blocking each 
caspase in the cascading mechanism(s), scientists can learn more about the overall 
apoptosis pathway(s). Our strategy involves constructing inhibitor molecules that will 
selectively inhibit the enzyme by bonding to it. By inhibiting each caspase, one at a time, 
we can possibly learn more about how to control the overall process of enzyme-regulated 
cell death. With the ability to control this process, scientists can ultimately generate new 
drugs that may induce programmed cell death in unwanted tissues (e.g. cancer tissue). 
New synthetic caspase inhibitors therefore could become tools for investigating the 
mechanism of caspase-dependent apoptosis.
2.2 Inhibitors
Inhibitors are molecules that block enzyme function and usually are structurally 
similar to a natural enzyme substrate. Although such molecules are unable to react, they 
compete with the substrate for the active site region of the enzyme, thereby blocking its 
activity. By blocking catalytic activity certain cellular events might be regulated or 
investigated.
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Enzyme substrates and many inhibitors have recognition positions within the active 
site (e.g. S2-S3’subsites; refer to Figure 2.4).^^ Recognition or binding sites are numbered 
according to their position relative to the site of peptide bond cleavage. The specificity of 
binding for a substrate or inhibitor is defined as a single site (e.g. P I ’) or as an extended 
region (e.g. P2-P2’) in the active site domain (Figure 2.4).^^ An enzyme-substrate or 
enzyme-inhibitor complex is often stabilized by a /S-pleated sheet structure consisting of 
hydrogen bonds and electrostatic interactions between the inhibitor (or substrate) and the 
amino acid residues in the active site.'
S2 S3'82' Enzyme81'
O.
b
Substrate
or
InhibitorO R O
Cleavage Site
P2 PI P I' P2' P3'
Figure 2.4 Substrate and inhibitor binding sites
Due to the similarity in structure and binding characteristics between natural 
substrates and natural inhibitors, a major strategy of drug development research involves 
the use of natural enzyme substrates as lead molecules for generating potent synthetic 
inhibitors. By this method, a myriad of inhibitors, including transition state analog 
inhibitors and substrate analog inhibitors have been developed.^^’̂ "'’̂ ^
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Substrate analog inhibitors are peptide substrates that differ from the natural enzyme 
substrate by one or more critical amino acid residues in the sequence. For example, an
unnatural amino acid incorporated into the primary sequence (Figure 2.5) 28
OH
OH
:
W n
Figure 2.5 Substrate analog inhibitor containing an unnatural phenylalanine residue 
(indicated by *)
Transition state analog inhibitors are peptide substrates which have been modified to 
resemble the tetrahedral intermediate that occurs in peptide hydrolysis (Figure 2.6 and
Figure 2.1).28
Enzyme
Peptide
Substrate
O
J L . . .A A
Inhibitor
AA" N 
.AA H
R
AA
Enzym e-SH E nzym e-S
AA
Hemithioacetal AA = am ino acid Enzym e- Inhibitor C om pex
(Tetrahedral Intermediate) (Transition-State Analog)
Figure 2.6 Transition state analog inhibitors of cysteine proteases
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The strength, or effectiveness, of a molecule for inhibiting a certain enzyme’s activity 
is determined by how well the inhibitor interacts with that enzyme and how well the 
inhibitor mimics catalytic intermediates. The first property is known as inhibitor 
specificity. For many protease inhibitors, specificity is usually determined by charged 
interactions over an extended region within the active site.^^ The more extensive the 
binding interactions are, the more specific the inhibitor will be.^  ̂ Furthermore, studies 
have shown that binding interactions on the leaving group side of the substrate or 
inhibitor (P l’-P4’ refer to Figure 2.4 page 12) contribute to a decrease in activation 
energy.^^ Caspases are among the most specific of proteases; they have a near absolute 
requirement for an aspartic acid residue at the PI subsite of the substrate.' Caspases have 
an equally stringent specificity for at least four amino acid residues, called a recognition 
motif, on the amino terminus side of the cleavage site (P1-P4, refer to Figures 2.2 and 
2.4), and it is clear that primary amino acid sequence recognition is a necessary 
requirement for catalysis and presumably for inhibitor binding.^"
The second property that determines inhibitor potency is the formation and stability 
of an artificial catalytic intermediate (e.g. tetrahedral intermediate) between the enzyme 
and the inhibitor. For caspases, an enzyme-inhibitor tetrahedral intermediate consists o f a 
hemithioacetal complex within the active site (refer to Figures 2.1 and 2.6), which forms 
by a reversible addition reaction.
The formation of a hemithioacetal is one example of a reversible addition reaction to 
a carbonyl containing compound. The simplest form of this reaction is hydration of a 
carbonyl compound. In this process, water adds across the carbonyl bond (C=0) to form 
the corresponding hydrate. Similarly, when an alcohol or thiol adds to the carbonyl
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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group, the initial product is called a hemiacetal or a hemithioacetal respectively (Figure 
2.7). '̂
©
OH2
R
H3O®
©
S - R
CT / "  (3
H e m ia c e ta l
H
OH2
 ̂ H3 O®
R R
H em ith io a c e ta l
Figure 2.7 Mechanism of hemiacetal and hemithioacetal formation
In this reaction, the carbonyl group changes from a trigonal planar sp^ hybridized carbon 
to a tetrahedral sp^ hybridized carbon, hence the name tetrahedral intermediate. Hydrate 
or hemiacetal formation is an equilibrium process where the equilibrium constant {Keq) 
can favor either the carbonyl compound or the tetrahedral product (e.g. hydrate, 
hemiacetal, etc). The position of equilibrium or the magnitude of Kgq depends upon the 
structure of each component of the reaction. In basic, acidic, or neutral water, simple 
carbonyl compounds are in equilibrium with their hydrates. Comparing the hydration 
reactions of different carbonyl compounds (e.g. trifluoroacetaldehyde, formaldehyde, 
chloroacetaldehyde, acetaldehyde and acetone), the Keq value has a wide variation (from 
10“̂ to 10'^) as shown in Table 2.1.^^
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Table 2.1 The Equilibrium Constant for Hydration of Carbonyl Compounds
C = 0  + HgO
R2
R i OH
r? \h
C arbon yl M o le c u le ^ e q
R-i= H, R 2= C F 3 2 .9 x 1 0 " ^
R-l — H, R 2" H 2 .3 x 1 0 ^
R^ — H, R 2— C H 2CI 3 7
R^— H, R 2— C H 3 1 .0 6
R-|— C H 3, R 2— C H 3 2  X 10'^
Alkene double bonds (C=C) are stabilized by alkyl group substitution. The greater the 
number of attached alkyl groups, the greater is the alkene’s stability. For example, the 
heat of formation (AHf°) o f 1-hexene is AHf° = -10 kcal/mol, whereas 
2,3-dimethylbutene is AHf° = -16 kcal/mol.^^ The more negative the heat of formation is 
for a compound, the more stable it is. Therefore 2,3-dimethylbutene, a tetrasubstituted 
double bond, is more stable than 1-hexene, a monosubstituted double bond. This rule also 
holds for C=0 double bonds (i.e. ketone vs. aldehyde). However, increasing alkyl 
substitution will also introduce steric destabilizations.^^ Therefore, increased substitution 
leads to increased stability in the carbonyl form and decreased stability in the hydrate 
form (Figure 2.8). This is the reason for a decreasing trend in Keg for the hydration of
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formaldehyde, acetaldehyde and acetone respectively (Table 2.1, entries 2, 4 and 5 
respectively).^^
Electron withdrawing groups such as chlorine or fluorine destabilize carbonyl groups 
when attached at the a  position (carbon directly attached to the C=0 group), by inductive 
removal of electron density.^^ Inductive destabilization of the carbonyl group favors the 
hydrate at equilibrium as shown in Table 2.1 and Figure 2.8. Fluorine is more 
electronegative than chlorine, which should increase the proportion of tetrahedral 
intermediate (or hydrate) relative to the carbonyl species. Therefore, 
trifluoroacetaldehyde is more hydrated at equilibrium than other carbonyl compounds 
(Table 2.1, entry 1 and Figure 2.8). In summary, as depicted in Table 2.1 and Figure 2.8,
H
/
H
C = 0
H3C\
/
H
'C = 0
H3 C,
> -o
HqC
Increased substitution  
by alkyl groups
yO H
H3 C OH
s ter ic  destabilization  
by alkyl groups
F3C
0=0
/
H
CIH2 C.
/
H
0=0
H3O
> =0
Hv
D estab ilized  by electron  
withdrawing group
Figure 2.8 The stability o f carbonyl groups and hydrates
aldehydes and ketones «-substituted with electron withdrawing groups (e.g. CF3) favor 
formation of a tetrahedral intermediate (Keg large) and therefore could stabilize 
hemithioacetal formation in a cysteine protease active site (Figure 2.9).
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0 
O
°  .E W G
E n zym e-S H  + -----------------> - E n z y m e - S ^ ^
^  a  —  i  ^
R = H or C Enzym e-Inhibitor C om p lex
EW G  = electron  withdrawing group
Figure 2.9 Transition state analog stability
Several commercial enzyme inhibitors have been generated on the basis o f this 
concept. Aldehydes have shown to be very potent reversible inhibitors in vitro, but are 
easily oxidized in vivo, reducing their effectiveness.^"^ Ketones are less stabilizing but 
allow for binding on both sides of the carbonyl group.^® When a strong electronegative 
group is added to the a-carbon of a methylketone, the tetrahedral intermediate is formed 
more readily, which increases the potency of a methylketone inhibitor.^^ However, if  the 
electronegative group is also a good leaving group, the inhibitor will be irreversible, 
which has been found with chloromethylketones (Figure 2.10 (a)).^  ̂Chlorine is a good
Inhib Irreversible ^   ,H ls
(a) . . y   3---   ,S
^  P j ?  F
/.V I n h l b ' ] ^ ^  , Re ve r s i bl e  In h ib 'J —
y S H  C y s - ^  H N ^ N H
C y s—
Figure 2.10 Reversible (b) and irreversible (a) inhibitors
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leaving group in nucleophilic substitution reactions and therefore these inhibitors bind 
irreversibly to the enzyme. In contrast, fluorine is a weak leaving group and is more 
electronegative than chlorine. So it will favor rapid formation of tetrahedral enzyme- 
inhibitor complex (Figure 2.10 (b)).’  ̂ Studies have shown that fluorinated inhibitors can 
stabilize a tetrahedral intermediate and increase the lifetime of an enzyme-inhibitor 
complex, thereby blocking normal enzyme function.^^
Within the enzyme active site, a peptide bond is hydrolyzed and the substrate is 
cleaved into two pieces (see Figure 2.1). In natural peptide hydrolysis, a catalytic 
intermediate called a tetrahedral intermediate is formed at the cleavage site. Since 
peptide-based inhibitors are designed to undergo the same mechanism, increasing the 
lifetime of this intermediate through stronger enzyme-inhibitor interactions leads to 
increased inhibitor potency. Strong enzyme inhibitor interactions occur through increased 
specificity (extended binding) and increased stability of the tetrahedral intermediate 
(Figure 2.11).
N-terminus
P3
C leavage Site
C-terminus
P2 P3'
H
N
N
H
N
H
P4P2‘
V-
IN C R EA SED  STABILITY IN C R EA SED  S P E C IF IC IT Y  
Figure 2.11 Specificity and stability o f proposed inhibitors
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Therefore, incorporation of fluorine into a peptide-based inhibitor molecule should lead 
to more potent inhibitor molecules. Several commercial peptide-based inhibitors are 
known but have limitations in terms of their specificity for caspases. Many of them only 
interact with the enzyme on one side of the cleavage site, reducing their specificity and 
potency.
2.3 The Aza-Allyl Anion 
The aza-allyl anion is a tool used in synthesis for constructing carbon-carbon bonds 
adjacent to nitrogen. There are three general strategies for such amine functionalization; 
nucleophilic substitution, radical substitution and electrophilic substitution.^^"^^ Each of 
these strategies is described in the following paragraphs.
Most classical syntheses employ nucleophilic substitution as the key step. In this 
reaction, a nucleophile will attack a carbon adjacent to the nitrogen. The second step of a 
Mannich reaction is one example of this method (Figure 2.12).^'
S tep  1 :
R ®
H ® / R
H 2C = 0  + HN^ ■ H2C=N + HoO
R R
Iminium Ion 
(M annich B a se )
S tep  2:
Nu
(nucleoph ile)
N e w  C -C  bond^
R
Figure 2.12 The Mannich reaction
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The first step of the Mannich reaction involves formation of an iminiiun ion (a.k.a. a 
Mannich base) from the condensation of an amine and an aldehyde or ketone. In the 
second step, the iminium ion is attacked by a carbon nucleophile at the a-carbon (carbon 
adjacent to nitrogen) to form a new carbon-carbon (C-C) bond.
Radical substitution at the a-earbon a second method for amine functionalization and 
the synthetic utility of this approach is at a promising stage of development. Almost all 
small radicals are short-lived, highly reactive species and can react or combine with a 
compound containing a multiple bond to produce a new larger radical and compound. 
The a-acylamino radical cyclization reaction depicted in Figure 2.13 is one example.'^^
or
R
O
New 0 -0  bond
OH
O
New 0 -0  bond
+
O
a -A cy lam in o  radical 
(carbon  radical)
Figure 2.13 The a-acylamino radical cyclization reaction
In this mechanism, a carbon radical is generated adjacent to nitrogen (a-carbon) by an 
initiator molecule and rapidly attacks a carbon-carbon multiple bond to form a new 
carbon-carbon (C-C) single bond. Although this reaction generally has low 
regioselectivity, it is possible to guide the regiochemical course of an a-acylamino 
radical cyclization by controlling olefinic substitution patterns.'*^
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Electrophilic substitution is the third method and provides a new general strategy for 
amine elaboration by charge affinity inversion of customary amine reactivity. A number 
of amine derivatives have shown that a-protons (on a-carhon) which are adjacent to a 
nitrogen hearing an electron withdrawing group (Z, Figure 2.14), can he acidic 
ipKa ^  20).'^° Thus a-carbanion amine synthetic equivalents (I, Figure 2.14) can be 
prepared. In electrophilic substitution, this a-carhanion serves as a nucleophile and the 
a-proton becomes replaced by an electrophile (E"̂ , Figure 2.14). The general scheme of 
this method is shown in Figure 2.14 below.^^
H
a  I . .  + Z
Ri--- C— NH ----------- -*
I I Step 1
Ro Rs
H
Ri C— N-
Ro R3
Step 2
0 
•  •  ##
-C— N-
R2 R3
Z— Stabilizing Group  ̂
(electron withdrawing)
Ri----- Ç— NH
R2 R3
Figure 2.14 General scheme of electrophilic substitution
Step 3
New C-C bond
- Z
Step 4
In Step 1 of this procedure, an activating group Z is added to the amine in order to 
increase the acidity of the a-proton. Subsequent removal of the a-proton (Step 2) under 
basic conditions gives the a-carbanion I. In Step 3 the a-carbanion nucleophile reacts
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with a carbon electrophile (E"̂ ) to form the new carhon-carbon (C-C) bond. Finally, the 
activating group (Z) is removed to yield the new unprotected amine product. The 
formation of an a-carhanion amine synthetic equivalent (I) by deprotonation of an amine 
derivative is the key to this methodology. The following paragraphs discuss each of the 
steps of amine electrophilic substitution in more detail.
The stabilizing group (Z) is a nitrogen protecting group but also functions as an 
activator by enhancing the acidity of the a-proton(s) adjacent to nitrogen. Figure 2.15 
depicts several types of amine activating groups which provide inductive and/or 
resonance stabilization to the forming a-carbanion."^^
G ^
R
G =  S, O 
(Thio)Amide
O W
II ,
RgN— P— N
I I  
RgN R
Phosphoram ide
V
0 = S = N - C R 2
A/-Sulfinylamine
CRz
CR;
R ^ N  
Imide
R
Nitrosoamine
V
S = C = N — C R 2
Isothiocyanate
/C R z
RO
I
R
Carbamate
NR
/C R z
I
R
Formamidine
© © Ijl 
C = N - C R 2
Isocyanide
R
Urea
0 0
.N® 
R
Amine
/C R g
R'" I '"CHR,
Oxide
mine
Figure 2.15 Types of activating groups
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Many activating groups also provide stabilization in the deprotonation step (Step 2, 
Figure 2.14), by coordinating with the metal counter-ion of the base used. Suitable Z- 
groups must be inert to any basic reagents used in the deprotonation step, must not 
interfere with the electrophilic substitution (Step 3, Figure 2.14) and must be 
conveniently and efficiently removed in Step 4 of the sequence."^^
The aza-allyl anion is an a-carbanion generated from an amine stabilized as an imine 
derivative (see Figure 2.16(a) and the boxed group in Figure 2.15)."̂  ̂ The aza-allyl anion 
is named for its similarity to the conventional allyl anion depicted in Figure 2.16(b); both 
structures have 4 n electrons delocalized over three atoms. In these molecules, Ri 
and/or R2 can be alkyl, aryl, ether, thioether, halogen or hydrogen g r o u p s . T h e  
conditions for generating the aza-allyl carbanion (Step 2, Figure 2.14) depend on the 
nature of the R3 substituent, which can be alkyl, hydrogen or electron withdrawing 
groups (e.g. ester or aryl).**̂  In all these molecules, the Z-group imine is usually generated 
in Step 1 of the sequence (Figure 2.14) by condensation of an aldehyde or ketone with the 
desired amine.
(a)
Ri
R2 N R3 
Im ine
R i, Rg = Alkyl; Aryl; S R ; O R ; X; H
N R3
A za-allyl an io n
R3 = Aikyl; H o r  E W G  (Aryl; -C O O R ) 
R i\f
R
A n o rm al allyl an io n
Figure 2.16 Structure of (a) an aza-allyl anion and (h) a normal allyl anion
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Formation of the aza-allyl anion can occur hy two general methods, as shown in 
Figure 2.17."̂  ̂Direct deprotonation usually involves proton abstraction by an alkyllithium 
(e.g. n-butyllithium, n-BuLi) or lithium amide base (e.g. lithium diisopropylamide, 
LDA). This method is suitable for imines derived from aldehydes and ketones which do 
not contain heteroatom substituents (i.e. R, and/or R2 = alkyl, aryl or H, Figure 2.17(a))."^"‘ 
For the more complicated imines, a tin-lithium exchange reaction has been found to work 
more effectively (i.e. R, and/or R2 = OR, SR, alkyl or H, Figure 2.17(b))."^® Once formed, 
the a-carhanion serves as a nucleophile for substitution and addition reactions with 
electrophiles such as alkyl halides and carbonyl compounds (Step 3, Figure 2.14).
(a)
Ri H
R N R
n-BuLi or LNR2  
 ̂ THF, -78°C
^ 1  SnBua
(b) JL JL n-BuLi or LNR2
R2"  N R
 ̂ THF, -78°C
^  y
Ra
1 ' JL
Figure 2.17 Formation of the aza-allyl anion hy (a) direct deprotonation with 
«-butyllithium («-BuLi) or lithium dialkylamide (LiNR2) in tetrahydrofuran (THF) and 
(h) tin-lithium exchange reactions
Step 4 of the overall reaction scheme (Figure 2.14, page 22) involves removal of the 
activating group Z. In the context of aza-allyl anion chemistry, several methods have 
been reported for the conversion of substituted imines to the corresponding amine 
products and most of these are simple acidic hydrolysis procedures." "̂*'^^
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CHAPTER 3
RESULTS
The primary focus of this work is successful development of a synthetic route to three 
/3-aminoketone molecules (2a -  c, Figure 3.1); precursors for a class of novel caspase 
inhibitors. The synthesis of subtargets 2 can be divided into two key parts, which
HoN HoN
2a 2b 2c
Figure 3.1 /S-Aminoketone subtargets 2a -  e
are described below. The first part involves a carbon-carbon bond forming reaction 
adjacent to nitrogen. The second part involves the preparation of 2-fluoro-, 2-methyl- and 
2-fluoro-2-methyl-4-pentenoyl species (3a, 3b and 3c respectively. Figure 3.7, page 39).
3.1 A-Methyl Imine Synthesis 
Currently, the most widely understood method used to form carbon-carbon bonds 
adjacent to the nitrogen of an amine functional group involves nucleophilic addition to
30
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the carbon attached to nitrogen.' In our approach, we used the electrophilic substitution 
reaction of aza-allyl anions (described in Chapter 2) generated from two diarylketone 
imines 4 and 5 (Figures 3.2 and 3.3).
The synthesis of A-methylbenzophenone imine 5 was accomplished in excellent yield 
(95%) by stirring a solution of methylamine hydrochloride and benzophenone imine in 
dichloromethane (CH2CI2) at 23 °C (>12 hr), according to a modified O’Donnell 
procedure (Figure 3.2).^ Following an ether extraction, the imine was isolated as a
CH2CI2
•NH CH 3N H2* H CI  ►
23°C
5 (95% yield) 
Figure 3.2 Synthesis of A-methylbenzophenone imine 5
viscous yellow oil and the purity was determined to be >95% by mass spectrometry and 
nuclear magnetic resonance (NMR) spectroscopy. A modified Weingarten procedure^ 
was used to prepare A-methyl-4-methoxybenzophenone imine 4 (Figure 3.3). In this case, 
an ice-cold solution of 4-methoxybenzophenone and methylamine in tetrahydrofuran 
(THF) was treated with titanium tetrachloride (0.6 equiv, 1.25 M in pentane). After 
slowly warming to a reflux, the mixture was cooled to 23 °C and then extracted with ether. 
Imine 4 was isolated in high yield (89%) and high purity (>95%, determined by mass 
spectrometry and NMR spectroscopy) as a viscous light yellow oil (1:1.5 mixture o f Z/E 
diastereomers).
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+ CH3 NH2
1)TiCl4, 0°C  
THF-pentane
2) Reflux
H3 C0 ^ ^ ^  H3CO'
4  (89% yield)
Figure 3.3 Synthesis of A-methyl-4-methoxybenzophenone imine 4
3.2 Imine Alkylation 
Using the new imine 4 and the A-methylbenzophenone imine 5, originally described 
by Kauffinann, Hullot and o t h e r s , o u r  first objective was to evaluate and optimize the 
reaction conditions for aza-allyl anion formation and alkylation. Although these anion 
nucleophiles have received a great deal of attention, several details of their reactivity, 
including the effect of certain reaction parameters are less understood (e.g. temperature 
and time of exposure to deprotonating agents).
In our approach, we first investigated deuterium incorporation as a method for 
determining the extent of anion formation under the conditions of direct deprotonation 
(see Chapter 2, Section 2.3) with «-butyllithium (n-BuLi). Table 3.1 summarizes the 
results of this initial study. For each case, a solution of 5 (0.268 M in THF) was treated 
with M-BuLi (1.20 equiv in THF) at -78 °C, followed by addition of a 1:1 mixture of 
deuterated methanol (C D 3 O D ) in deuterium oxide (D 2 O) after the period of time 
indicated in Table 3.1. The metallation temperature was held at -78 °C in every case
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except entry 4, where the temperature was increased to 0 °C for 5 min, after 1 hr at 
-78 °C.
Table 3.1 Deuteration of the Aza-Allyl Anion of A-Methylbenzophenone Imine
1) n-BuLi (1.2 equiv),
THF, "conditions" P h . P h . M .
CHs ______ :______________ ^  ^CHgD +
2) CD3OD/D2O (5 equiv)
Ph -78 ° c  to -23 °C Ph Ph
5
Entry Conditions Product Ratio (D : H)  ̂ Yield (%)*̂
'CH 3
1 -78 °C, 20 min^ 1 :3 .8 98
2 -78 X ,  1 hr 1.4 : 1 97
3 -78 X ,  2 hr 1.7 :1 92
4 -78 X ,  1 hr; 0 X ,  5 min 8.1 : 1 97
^Determined by ^H NMR integration. '^Total m ass recovered. ^1.10 equiv of n-BuLi
Following extraction and work-up, the products were analyzed by proton ('H) NMR 
spectroscopy to determine the ratio of deuterated and non-deuterated imines. The results 
demonstrated that aza-allyl anion formation occurs efficiently at a temperature slightly 
higher than -78°C when the imine is directly deprotonated with n-BuLi.
Given the results of our deuterium incorporation study, we investigated the 
comparative alkylation of imines 4 and 5 employing four alkyl halides (Tables 3.2 and 
3.3). In this approach, we developed a high yielding general procedure for aza-allyl anion 
alkylation using carefully controlled metallation conditions. In each case, a solution of 
A-methyl imine (4 or 5) in THF (0.60 M) was added dropwise to a solution of «-BuLi
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(0.60 M, 1.25 equiv, in THF) at -78 °C. The resulting red-brown solution was stirred at 
-78 °C for one hour and then warmed to 0 °C for 5 minutes to ensure complete 
deprotonation. After re-cooling the mixture to -78 °C, an alkyl halide electrophile
Table 3.2 Alkylation of A-Methylbenzophenone Imine
p u  1)n-B uLi,TH F,-78°C
2) R - X, -78 °C, 4.5 hr
6 - 9
Entry Alkyl Halide Product Conversion (%)® Isolated Yield (%)
1 CH3I 6 82 78""
2 (CH3)2CHCH2Br 7 99 95
3 CH2=CHCH2Br 8 93 77
4 CgHgCH2Br 9 95 81
^Determined by NMR analysis. ‘̂ Product isolated by flash chromatography.
(1.5 equiv) was added neat and stirring was continued at -78 °C for an additional 4.5 
hours. Following extraction and work-up, the crude products were analyzed by 'H  NMR 
spectroscopy to determine the percent conversion of starting material to alkylated 
products. As shown in Tables 3.2 and 3.3, all reactions proceeded quantitatively. In 
addition, excellent yields of purified alkylation products were isolated following 
Kugel-Rohr distillation under reduced pressure (50 juTorr).
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Table 3.3 Alkylation of A-Methyl-4-Methoxybenzophenone Imine
1)n-B uLi,TH F,-78 °CCH
2) R—X , -78 "C, 4 .5  hr
H3CO H3CO
Entry Alkyl Halide Product Conversion
N R
1 0 - 1 2
Isolated Yield (%)
1
2
3
(CH3)2CHCH2Br
CH2=CHCH2Br
CgHsCHgBr
10
11
12
94
90
88
81
86
80
^Determined by ^H NMR analysis.
Several different procedures have been reported for removing the imine protecting 
group following an electrophilic substitution reaction, including concentrated HCl, 
ammonium hydroxide in ethanol (at pH 4-6) and aqueous citric acid.^''*’ Given the range 
of these eonditions, we ran a test experiment to confirm that a simple acid hydrolysis 
procedure would be a viable method for our purposes. In this experiment, a solution of 
A-(2-phenylethyl)benzophenone imine (9) in diethyl ether (0.50 M) was treated with a 
IN solution of aqueous HCl at 23 °C for 12 hours. Following work-up, the corresponding 
2-phenylethylamine was isolated in 67% yield as a viscous yellow oil.
3.3 Substitution and Addition Reactions 
Our next objective was to examine the reaction of imines 4 and 5 with various 
acylating agents including carboxylic acid chlorides, anhydrides, amides and esters.
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O O
(a) (c) (e)
H,C Cl HgC O CHs "OCH;
(b) (d) .CHc (f)
H N
CHs
O CH.
Figure 3.4 Imine acylating agents: (a) acetyl chloride (b) benzoyl chloride (c) acetic 
anhydride (d) A,Af-dimethyl formamide (e) methyl benzoate and (f) ethyl fluoroaeetate
Figure 3.4 shows several of the acylating agents used in this study. These substitution 
reactions were carried out in the same manner as the alkylation reactions, where 
A-methylbenzophenone imine (5) was deprotonated with n-BuLi in THF at -78 °C. 
Following the deprotonation period (-78 °C, 1 hr then 0 °C 5 min) an acylating agent 
(1.5 equiv) was added neat and stirring was continued at -78 °C for 4.5 hours. No 
reaction was observed for acetic anhydride, acetyl chloride or benzoyl chloride, even at 
long reaction times (>18 hr). At higher temperatures, we observed a considerable amount 
of starting material decomposition. In spite of these findings, modest yields of 
jS-iminoketone products were obtained with the methyl henzoate and ethyl fluoroaeetate 
esters (72% and 41% respectively. Figure 3.5). For the latter reaction 'H  NMR analysis 
indicated nearly quantitative conversion to the /3-iminofluoroketone product 14. However, 
this compound proved to be unstable and significant yields were difficult to isolate.
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Ph
(a)
N.
'CH.
Ph
5
1)n-BuLi, THF,-78 "C
AH sC O ^'^Ph , -78 °C, 6 hr
Ph^ .̂N 
Ph
Ph
13 (72% yield)
(b)
Ph
5
1)n-BuLi, THF, -78 X
2 ) O
F , -78 X , 10 hr
Ph^ .̂N 
Ph
14 (41% yield)
Figure 3.5 Reaction conditions and isolated yields for (a) methyl benzoate and (b) ethyl 
fluoroaeetate substitution reactions
As an alternative strategy to forming the desired subtargets 2a -c (refer to Figure 3.1, 
page 30), we also investigated aldehyde electrophiles. Nucleophilic addition of an aza- 
allyl anion derived from either 4 or 5 to an aldehyde, should provide a jS-imino-alcohol 
product, which could be subsequently oxidized to the corresponding /3-iminoketone as 
shown in Figure 3.6. In order to explore this strategy, we compared the additon reactions
Oxidation P h . .N
R H,N.
Figure 3.6 Alternative route to subtarget 2
of imines 4 and 5 with four aldehyde electrophiles (Table 3.4). In each case, the A-methyl 
imines were deprotonated with «-BuLi in THF at -78 °C. Following the deprotonation 
period (-78 °C, 1 hr then 0 °C, 5 min) an aldehyde (1.5 equiv) was added neat and
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stirring was continued at -78 °C for 15 - 25 hours. Following extraction and work-up, the 
crude products were analyzed by 'H NMR spectroscopy and gas chromatography (GC) to 
determine the percent conversion of starting material to addition products. As shown in 
Table 3.4, modest yields of jS-imino alcohol products were obtained with both imine 
nucleophiles, but the isolation proved to be problematic, especially for the 
4-methoxybenzophenone imine derivatives (Table 3.4, entries 2 and 4).
Table 3.4 Aldehyde Addition Reactions with iV-Methyl Imines 4 and 5
OH
1)n -B u L i,T H F ,-78°C
Ô 2) 9
H ^ R ’, -78 °C , 15 - 2 5  hr Ô
4: R = OCH3 
5: R = H
1 5 - 2 0
Entry Imine Aldehyde Product Conversion { % f Isolated Yield (%)
1 5 CH3(CH2 )2 CH0 15 60 46
2 4 CH3 (CH2 )2CH0 16 50 37
3 5 (CH3)3CCH0 17 92 89
4 4 (CH3 )3CCH0 18 84*̂ —
5 5 CH3CH=CHCH0 19 79 76
6 5 GeHsCHO 20 70 32
^Determined by NMR analysis. “̂ Determined by GC analysis.
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3.4 Pentenoic Acid Analogs 
The synthesis of /3-aminoketone subtargets 2a -  c (Figure 3.1, page 30) involves two 
key parts, the first of which has been described in the preceding sections. The second part 
involves the preparation of 2-fluoro-, 2-methyl- and 2-fluoro-2-methyl-4-pentenoyl 
species (3a, 3b and 3c respectively. Figure 3.7) and coupling of these electrophiles to an 
imine nucleophile.
X = H ,C I, OR, NRs
X
3c3a
Figure 3.7 2-Fluoro-, 2-methyl- and 2-fluoro-2-methyl-4-pentenoic acid analogs 3a  -  c
Since compounds 3a -  c are all 4-pentenoic acid derivatives, we synthesized the 
corresponding 4-pentenoic acids (22a -  c. Figure 3.8) in high yields (87% -  95%) using 
established literature methods."^ In each case, a solution (0.20 M) of psuedoephedrine 
carboxamide (21a -  c) in a 1:1 mixture o f t-butyl alcohol (t-BuOH) and methanol 
(CH3OH) was treated with a 2N solution of aqueous NaOH at 75 °C for 4 hours. 
Following work-up, the corresponding 4-pentenoic acids were isolated as colorless oils. 
Carboxamides 21a and 21c were synthesized from a pseudoephedrine fluoroacetamide 24  
(not shown) according to the literature procedures.''*’’'̂  Alkylation of 24 with allyl iodide 
(lithium A,A-bis(trimethylsilyl)amide, LiCl, THF, -78 °C; allyl iodide, -78 °C) provided 
21a as a viscous light-yellow oil (89%) after work-up and purification by flash column
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CH
OH CH
21a
OH CH3 R CH3
21b; R = H 
21c: R = F
NaOH (aq)
f-BuOH, CH3OH, 75 °C
22a (95% yield
R CH3
22b: R = H (88% yield) 
22c: R = F (87% yield)
Figure 3.8 Synthesis of 2-fluoro-, 2-methyl- and 2-fluoro-2-methyl-4-pentenoic acids 
2 2 a -c
chromatography. Méthylation of 24 by a similar procedure (lithium 
A(iV-bis(trimethylsilyl)amide, LiCl, THF, -78 °C; iodomethane, -50 °C) provided a 
fluoropropionamide (not shown) in 97% yield. Subsequent alkylation with allyl iodide 
(LDA, LiCl, THF, -78 °C; allyl iodide, -78 °C) provided the 2-fluoro-2-methyl 
carboxamide 21c in 80% yield as a viscous colorless oil. Carboxamide 21b was prepared 
in the same manner (96% yield) from a pseudoephedrine propionamide (not shown) by 
alkylation with allyl iodide (LDA, LiCl, THF, -78 °C; allyl iodide, 0 °C, 45 min). In 
addition, 2-fluoro-2-methyl-4-pentenal (23, Figure 3.9) was synthesized in 78% yield 
form carboxamide 21c by reduction with lithium triethoxyaluminum hydride 
[LiAlH(OEt)s] according to the procedure of Myers.
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CH
21c
LiAlH{OEt)3
Hexane - THF, -78 °C to 0 “G F CHg 
23 (78% yield)
Figure 3.9 Synthesis of 2-fluoro-2-methyl-4-pentenal 23
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CHAPTER 4
DISCUSSION AND FUTURE WORK 
The primary objective of this work was to develop a synthetic route to three 
jS-aminoketone molecules 2a -  c; precursors for a class of novel caspase inhibitors 
(Figure 3.1, page 30). Although synthesis of the three subtarget molecules was not 
completed, several fundamental aspects of the synthetic approach were established. First, 
a general, high yielding procedure for carbon-carbon bond formation was developed 
involving aza-allyl anion alkylation, substitution and addition. Second, substituted 
4-pentenoic acid molecules (3a -  c. Figure 3.7, page 39) necessary for the synthesis of 
subtargets 2a - c were prepared in high yield.
4.1 Aza-Allyl Anion Formation 
We investigated two A-methyldiaryl imines in an effort to establish a general, high 
yielding procedure for carbon-carbon bond formation adjacent to nitrogen in protected 
amine synthetic equivalents. Using A-methylbenzophenone imine (5), we conducted 
deuterium incorporation studies to determine the approximate extent of 
(X-deprotonation with w-butyllithium (n-BuLi) at -78 °C. We chose to use «-BuLi as the 
deprotonating agent because of previous reports by Hullot and Kauffinann who 
independently investigated the alkylation of aza-allyl anions derived from
43
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A-methylbenzophenone imine (5).’’̂  In the only other recorded deuterium incorporation 
study, Kauffmann estahlished that anion formation, from imine 5, was occurring to a 
reasonable extent (84% at -60 °C for 30 min) in the presence of lithium diisopropylamide 
(LDA).^ Comparing n-BuLi with lithium diisopropylamide (LDA) and lithium 
diethylamide (LiNEt:) bases, Hullot and Kauffmann claimed that n-BuLi consumed 
>10% of the imine by direct addition to the C=N bond, yet their overall alkylation 
product yields were 20% higher with n-BuLi?"^ In our preliminary deuterium 
incorporation study we did not observe products resulting from direct nucleophilic 
addition by n-BuLi and cleanly recovered >92% of combined deuterated and 
non-deuterated products, in each case. Although this was not intended as a classical 
kinetic study, it did provide a standard protocol for imine metallation in alkylation, 
substitution and addition reactions, which proved to be high yielding for both 
A-methylbenzophenone imine (5) and A-methyl-4-methoxybenzophenone imine (4). 
With this initial study we clearly demonstrated that aza-allyl anion formation occurs 
efficiently (>90%) when A-methylbenzophenone imine is directly deprotonated with n- 
BuLi under closely controlled metallation conditions.
4.2 A-Methyl Imine Alkylation 
Our next objective involved the comparative alkylation of aza-allyl anions derived 
from A-methylbenzophenone imine (5) and A-methyl-4-methoxybenzophenone imine
(4). First, using the direct deprotonation protocol established in our deuterium 
incorporation study and four alkyl halides, we obtained very high isolated yields (77% to 
95%) of alkylation products (see Table 3.2, page 34) with A-methylbenzophenone imine
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(5). In previous work, summarized in Table 4.1, Hullot and Kauffmann independently 
reported that the aza-allyl anion formed from 5 with lithium diisopropylamide or lithium 
diethylamide bases (LDA or LiNEt:) in THE at -70 °C to -60 °C result in decent yields 
(58% - 81%) for primary and secondary alkyl halides, especially when the concentration 
of HMPA (1,1,1,3,3,3-hexamethylphosphorustriamide) is minimal (compare entry 4 and 
entry 5).’'̂
Table 4.1 Reported Alkylation of A-Methylbenzophenone Imine
Ph
1 ) deprotonation Ph
P h " ^ N " ^2 ) electrophile
Entry Conditions® Electrophile^^ Yield (%) Reference
1 A CH3CH2CH2CI 81 2
2 B CH3(CH2)6CH2Br 64 3
3 A (CH3)2CHCH2Br 69 2
4 A CH3CH2(CH3)CHBr" 18 2
5 A CH3CH2(CH3)CHBr 70 2
6 B CH2=CHCH2Br 58 3
7 A C6H5CH2CI 64 2
= LiNEt2 (1.12 equiv) in HMPA-benzene at -70 °C for 1.5 hr; B = LDA 
(1.0 equiv) in THF at -60 °C for 30 min. *̂ 1.20 equiv dissolved in THF.
'1.20 equiv dissolved in HMPA.
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Compared to this earlier work, we have demonstrated that direct deprotonation of 
A-methylbenzophenone imine (5) with n-BuLi (in THF) at -78 °C, results in alkylation 
product yields that are more than 30% higher than those previously reported.
Due to the electron donating effect of a 4-methoxy group, we anticipated that 
A-methyl imine 4 would be slightly more reactive compared to imine 5 and result in 
higher yields. However, as shown in Table 3.3 (page 35), the overall yields (80% -  92%) 
were comparable. Therefore, these results confirmed that efficient aza-allyl anion 
formation occurs with the deprotonating agent n-BuLi at -78 °C.
4.3 Substitution and Addition Reactions 
Continuing our investigation of the functionalization of protected amine synthetic 
equivalents, we next focused on acylation reactions. This approach would involve 
nucleophilic substitution by aza-allyl anions on various carboxylic acid derivatives, such 
as acid chlorides, anhydrides and esters. Unfortunately, all of our attempts to acylate the 
anions derived from A-methyl imines 4 and 5 with benzoyl chloride, acetyl chloride or 
acetic anhydride failed. After numerous unsuccessful reactions using the standard 
protocol for imine alkylation, we explored other reaction modifications, including longer 
reaction times (>18 hr after addition of the electrophile), higher temperatures (-60 °C to 
-45 °C) and complexation of the acylating agent with a Lewis acid. In nearly all attempts, 
we recovered unreacted starting material and unidentified decomposition products.
In contrast to the acid chlorides and anhydrides, we obtained modest yields of 
j8 -iminoketone products (41% - 72%) derived fi’om methyl benzoate and ethyl 
fluoroacetate (Figure 3.5, page 37). Compared to acid chlorides and anhydrides, esters are
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usually less reactive acylating agents. However, the successful ester substitutions indicate 
that other side reactions may have been occurring with the former acylating agents. We 
also found the two crude jS-iminoketone products (13 and 14) to be unstable for extended 
periods of time. In fact, the 3-fluoro-2-ketoimine 14 was extremely unstable and 
significant yields were difficult to isolate. In spite of this, the successful acylation of an 
aza-allyl anion with ethyl fluoroacetate is a very important result because subtargets 2 a 
and 2c (Figure 3.1, page 30) are presumably available from substituted 3-fluoro-2- 
ketoimines derived from fluorinated acid derivatives (see Figure 3.7, page 39).
Our final objective in developing an effective procedure for carbon-carbon bond 
formation in protected amine equivalents, involves aza-allyl anion addition reactions. In 
this approach we treated aza-allyl anions derived from A-methyl imines 4 and 5 with four 
aldehyde eletrophiles. As shown in Table 3.4 (page 38), we generally observed decent 
overall reactivity with aldehydes. The highest percent conversions, from starting material 
to product, were observed with the pivaldehyde (84% and 92%), crotonaldehyde (79%) 
and benzaldehyde (70%) electrophiles. In contrast, the reaction with butyraldéhyde was 
only 50% -  60%. Of these four compounds, only butyraldéhyde contains acidic 
a-hydrogens. In the butyraldéhyde addition reactions of anions derived from 4 and 5 
(Table 3.4, entries 1 and 2, page 38), the aza-allyl anion likely competed as both a base 
(deprotonation at the a-carbon) and as a nucleophile, resulting in low yields (37% - 46%) 
of /3-imino alcohol products 15 and 16. For all of our imine substitution and addition 
reactions we found high-vacuum (50 juTorr) Kugel-Rohr distillation to be overall the 
most effective method for product isolation, but as indicated in Table 3.4 only significant 
yields of products 17 (89%) and 19 (76%) were obtained. Hullot and Cuvigny have
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reported the best known examples of jV-methylbenzophenone imine addition reactions 
with aldehydes and ketones (Figure 4.1)?
1)n-BuLi,THF,-70 °C, 
10% HMPA, 30 min
OH
(a)
CH3 
Ph 2 ) OX
5 H " ^ P h ,T H F  63% yield
Ph N
Ph
Ph
1)n-BuLi,THF,-70 °C,
10% HMPA, 30 min Ph. M
C H .  _
(b) 2) O
OH
Ph
Ph l|^  Ph
5 Ph Ph 62% yield
Ph
Figure 4.1 Addition reactions of A-methylbenzophenone imine (5) with (a) benzaldehyde 
and (b) benzophenone
These authors reported isolated yields of ~60% as optimum using «-BuLi as the base (at 
-70 °C) in THF with 10% HMPA added as a co-solvent.^ In contrast, they found that the 
use of an HMPA co-solvent was not as effective for improving yields in the substitution 
reactions. In fact, they reported that increasing the ratio of THF in the reaction mixture by 
dissolving the alkyl halide in THF (vs. HMPA) resulted in a dramatic increase in product 
yield (see Table 4.1 entries 4 and 5).^ Overall, these results indicate that aldehyde 
electrophiles are comparable in yield to the previously described ester electrophiles 
(although they required longer reaction times).
To conclude the first part of the main objective of this thesis work, we employed 
deuterium labeling studies as well as alkylation, substitution and addition reactions with
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aza-allyl anions derived from two iV-methyl imines, to establish the framework of a 
synthetic procedure for preparing three /3-aminoketone molecules. A general, high 
yielding method for carbon-carbon bond formation and protected amine functionalization 
was developed that uses a direct deprotonation protocol and carefully controlled reaction 
conditions. Based on our results, the metallation of non-activated diarylimines 4 and 5 
with M-BuLi (in THF) at -78 °C (1 hr then 0 °C for 5 min) is overall a more effective 
procedure than those previously described.
4.4 Pentenoic Acid Analogs 
The second goal in developing a successful synthetic route to the three 
j(3-aminoketone molecules 2a -  c (Figure 3.1, page 30) consists of preparing substituted 
4-pentenoic acid derivatives 3a -  c (Figure 3.7, page 39). Accordingly, all three of the 
corresponding 4-pentenoic acids (22a -  c) as well as 2-fluoro-2-methyl-4-pentenal (23) 
were successfully synthesized in high yields from commercially available materials. In 
addition, we prepared acid chloride derivatives corresponding to 3a and 3b (X = Cl) in 
excellent yield (92% and 96% respectively). Since this group of subunit molecules 3a - c 
provide the structural features responsible for increased specificity and stability in the 
final inhibitor products (see Figures 1.1, 1.2 and Chapter 2.2), these derivatives are 
critical to the long range goal of caspase inhibitor synthesis. Molecules 3a and 3c are 
fluorinated while 3b is not and the inhibitors ultimately derived from these precursors 
will be used to determine whether a quaternary-, tertiary-, or non-fluorinated center 
affects inhibitor specificity and potency.
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4.5 Future Work
The major objective of this research project is construction and bioanalysis of a 
homologous series of peptide-based caspase inhibitors which are designed to improve 
inhibitor specificity, stability and potency. Once these new inhibitors have been 
constructed we will perform preliminary tests with commercial recombinant caspase 
enzymes known to be involved in apoptosis. Successful construction of the new 
inhibitors requires preparation of subunits 2a - c, oxidation of the alkene moiety, and 
coupling on both the N-terminal and C-terminal ends with various combinations o f amino 
acid residues. The amino acid residues selected for incorporation will be chosen on the 
basis of established specificities in serine proteases (similar to cysteine proteases) and in 
caspases known to affect apoptosis (e.g. caspases 3, 8  and 9).
Immediate future work will focus on investigating the reaction of Wmethyl imine 
aza-allyl anions with various derivatives of the three 4-pentenoic acids (22a -  c). 
Although we found substitution reactions with acid chlorides to be problematic, we were 
able to successfully form /3-iminoketone products from ester derivatives. Therefore, 
preparation of alkyl 4-pentenoate esters (3a -  c where X = OR) and their reaction with 
A-methyl imine 4 or 5 is a top priority. Also important is the synthesis of two other 
4-pentenaldehyde derivatives (3a and 3b where X = H) and subsequent A-methyl imine 
addition reactions.
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CHAPTER 5
EXPERIMENTAL
5.1 Materials and Methods
All reactions were performed in oven or flame-dried glassware under an atmosphere 
of dry argon unless otherwise noted. Air- and moisture-sensitive liquids and solutions 
were transferred via syringe or cannula. Proton and carbon nuclear magnetic resonance 
('H NMR and '^C NMR) spectra were recorded at 400 MHz and 100 MHz respectively. 
Infrared (FTIR) spectra were obtained as neat films unless otherwise specified. Flash 
column chromatography was performed as described by Still' employing 230 - 400 mesh 
silica gel.
Commercial reagents and solvents were used as received with the following 
exceptions. Tetrahydrofuran and diethyl ether were distilled from sodium-benzophenone 
ketyl. Dichloromethane, diisopropylamine, AA-bis(trimethylsilyl)amine, ethyl acetate, 
xylene and hexane were distilled from calcium hydride under an atmosphere o f nitrogen. 
Methanol and 2-butanol were distilled from magnesium under an atmosphere o f argon. 
Pentane was purified by passage through a column of silica gel followed by distillation 
from sodium hydride under an atmosphere of nitrogen. Benzoyl chloride was distilled 
from calcium chloride under an atmosphere of nitrogen. Acetyl chloride was distilled 
from thionyl chloride under an atmosphere of nitrogen. Acetic anhydride was distilled
52
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from phosphorus pentoxide under an atmosphere of nitrogen. Benzyl bromide, isobutyl 
bromide, allyl bromide, iodomethane, methyl benzoate, ethyl fluoroacetate and 
benzaldehyde were passed through neutral alumina (activity II) immediately prior to use. 
The molarity of «-butyllithium was determined by titration against a standard solution of 
2 -butanol in xylenes using 1 ,1 0 -phenanthroline as an indicator (average of three 
determinations).^ A standardized solution of titanium tetrachloride in pentane (1.25 M) 
was prepared by dilution of commercial titanium tetrachloride in freshly distilled pentane 
under an atmosphere of argon.
5.2 Imine Synthesis and Alkylation 
A-MethyI-4-methoxybenzophenone imine (4): Prepared according to a modified 
Weingarten procedure.^ An oven-dried 100-mL round-bottomed flask equipped with a 
magnetic stirring bar and a rubber septum, was charged with 4-methoxybenzophenone 
(4.14 g, 19.5 mmol, 1 equiv) and methylamine (2.00 M in tetrahydrofuran, 48.8 mL,
97.6 mmol, 5.0 equiv), then purged with argon. The resulting suspension was cooled to 
0 “C and titanium tetrachloride (1.25 M in pentane, 9.37 mL, 11.7 mmol, 0.6 equiv) was 
added dropwise by syringe. The mixture was stirred at 0 °C for an additional 1.5 hr, 
refluxed for 3 hr and then permitted to stir at 23 °C. After 12 hr the mixture was 
partitioned between ether (50 mL) and water (50 mL). The aqueous layer was separated 
and extracted further with three 10-mL portions of ether. The combined organic layers 
were washed with a saturated aqueous sodium chloride solution, then dried over 
anhydrous sodium sulfate and concentrated to furnish a viscous light-yellow oil (3.90 g, 
89%). 'H  NMR (CDCI3) (1:1.5 mixture of Z/E diastereomers, * denotes Z isomer peaks):
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ô 7.86-6.78 (m, 18H), 3.89 (s, 3H), 3.81* (s, 3H), 3.31 (s, 3H), 3.21* (s, 3H); '^C NMR 
(CDCI3): ô 168.9, 163.1, 136.7, 132.6, 129.6, 128.4, 128.2, 128.1, 127.9, 113.2, 55.1, 
41.1; FTIR: 3056 (m), 3001 (m, aromatic C-H), 2934 (m), 2909 (m), 2836 (m, alkane 
C-H), 1606 (s, C=N), 1250 (s), 1034 (m) cm '.
A-Methylbenzophenone imine (5): Prepared according to a modified O’Donnell 
procedure."' An oven-dried 100-mL round-bottomed flask equipped with a magnetic 
stirring bar and a rubber septum, was charged with a solution of methylamine 
hydrochloride (0.675 g, 10.0 mmol, 1 equiv) in dichloromethane (40 mL) and purged 
with argon. A solution of benzophenone imine (1.81 g, 10.0 mmol, 1 equiv) in 
dichloromethane (5 mL) was added dropwise via syringe and the resulting mixture was 
stirred at 23 °C under a dry atmosphere (argon passed through a calcium sulfate drying 
tube). After four days the mixture was partitioned between ether (50 mL) and water 
(50 mL). The combined organic layers were washed with a saturated aqueous sodium 
chloride solution, then dried over anhydrous sodium sulfate and concentrated to fiimish a 
viscous yellow oil (1.86 g, 95%). 'H NMR (CDCI3): ô 7.60-7.15 (m, lOH), 3.26 (s, 3H); 
'^C NMR (CDCI3): Ô 169.5, 140.0, 136.7, 129.9, 128.6, 128.4, 128.3, 128.1, 127.9,41.6; 
FTIR: 3057 (m), 3024 (m, aromatic C-H), 2945 (m), 2913 (m), 2859 (m, alkane C-H), 
1626 (s, C=N) cm '.
A-Ethylbenzophenone imine (6): An oven-dried 25-mL round-bottomed flask equipped 
with a magnetic stirring bar and a rubber septum was charged with tetrahydrofuran 
(10 mL) and purged with argon. After cooling to -78 °C, n-butyllithium (2.21 M in 
hexane, 2.91 mL, 6.43 mmol, 1.20 equiv) was added by syringe. A solution of imine 5 
(1.05 g, 5.36 mmol, 1 equiv) in tetrahydrofuran (20 mL) was transferred dropwise by
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syringe, over a 30 minute period. Upon completion of the addition, the red-brown 
suspension was stirred at -78 °C for 1 hr, at 0 °C for 5 min and then cooled to -78 °C. 
Iodomethane (1.52 g, 10.7 mmol, 2.0 equiv) was added to the reaction flask by syringe 
and stirring was continued at -78 °C for 4.5 hr. The reddish-brown mixture was warmed 
to 23 °C and then partitioned between dichloromethane ( 6  mL) and water ( 6  mL). The 
aqueous layer was separated and further extracted with three 6 -mL portions of 
dichloromethane. The combined organic layers were washed with a saturated aqueous 
sodium chloride solution, then dried over anhydrous sodium sulfate and concentrated. 
The resulting orange oil was purified by flash chromatography (10% ethyl acetate in 
hexane) to provide a clear yellow oil (0.872g, 78%). 'H NMR (CDCI3): Ô 7.62-7.00 (m, 
lOH), 3.40 (q, J = 7.3 Hz, 2H), 1.25 (t, J = 7.2 Hz, 3H); NMR (CDCI3): Ô 167.6,
140.0, 136.9, 132.4, 130.0, 129.7, 128.4, 128.3, 127.9, 127.7, 48.2, 16.3; FTIR: 3056 (m), 
3024 (m, aromatic C-H), 2954 (s), 2858 (m, alkane C-H), 1625 (s, C=N) cm''. 
A-(3-MethyIbutyl)benzophenone imine (7): An oven-dried 50-mL round-bottomed 
flask equipped with a magnetic stirring bar and a rubber septum was charged with 
tetrahydrofuran (18 mL) and purged with argon. After cooling to -78 °C, «-butyllithium 
(2.75 M in hexane, 3.29 mL, 9.05 mmol, 1.25 equiv) was added by syringe. A solution of 
imine 5 (1.41 g, 7.24 mmol, 1 equiv) in tetrahydrofuran (14 mL) was transferred 
dropwise by syringe, over a 30 minute period. Upon completion of the addition, the 
red-brown suspension was stirred at -78 °C for 1 hr, at 0 °C for 5 min and then cooled to 
-78 °C. Isobutyl bromide (1.18 g, 10.9 mmol, 1.5 equiv) was added to the reaction flask 
by syringe and stirring was continued at -78 °C for 4.5 hr. The reddish-brown mixture 
was warmed to 23 °C and then partitioned between dichloromethane ( 6  mL) and water
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( 6  mL). The aqueous layer was separated and further extracted with three 6 -mL portions 
of dichloromethane. The combined organic layers were washed with a saturated aqueous 
sodium chloride solution, then dried over anhydrous sodium sulfate and concentrated. 
The resulting orange oil was purified by high-vacuum (50 juTorr) Kugel-Rohr distillation 
to provide a viscous orange oil (1.73 g, 95%). 'H  NMR (CDCI3): 6  7.82-7.0 (m, lOH), 
3.39 (t, J = 7.21 Hz, 2H), 1.68 (m, IH), 1.57 (q, J = 7.22 Hz, 2H), 0.83 (d, J = 6.50 Hz, 
6 H); NMR (CDCI3): ô 167.6, 140.0, 137.0, 129.6, 128.3, 128.2, 128.1, 52.1, 40.2,
24.9, 22.6; FTIR: 3058 (m), 3025 (m, aromatic C-H), 2954 (s), 2867 (m, alkane C-H), 
1624 (s, C=N) cm '.
A-(3-ButenyI)benzophenone imine (8): The alkylation of A-methylbenzophenone imine 
(1.65 g, 8.45 mmol, 1 equiv) in tetrahydrofuran (40 mL) with allyl bromide (1.53 g,
12.7 mmol, 1.5 equiv) was carried out as described for 7. Purification of the resulting 
residue by high-vacuum (50 fiTon) Kugel-Rohr distillation provided a viscous yellow oil 
(1.53 g, 77%). 'H NMR (CDCI3): ô 7.60-7.02 (m, lOH), 5.88-4.84 (m, 3H), 3.43 (t, 
J = 7.16 Hz, 2H), 2.45 (q, J -  7.03 Hz, 2H); '"C NMR (CDCI3): ô 167.9, 136.9, 129.8,
128.6, 128.3, 128.0, 127.8, 127.9, 127.2, 126.0, 115.6, 53.2, 35.5; FTIR: 3057 (m), 3023 
(m, aromatic C-H), 2954 (s), 2857 (m, alkane C-H), 1623 (s, C=N) cm"'. 
A-(2-Fhenylethyl)benzophenone imine (9): The alkylation of A-methylbenzophenone 
imine (1.38 g, 7.09 mmol, 1 equiv) in tetrahydrofuran (28 mL) with benzyl bromide 
(1.27 g, 10.6 mmol, 1.5 equiv) was carried out as described for 7. Purification of the 
resulting residue by high-vacuum (50 juTorr) Kugel-Rohr distillation provided a viscous 
yellow oil (1.63 g, 81%). 'H  NMR (CDCI3): ô 7.67-6.79 (m, 15H), 3.63 (t, J -  7.26 Hz, 
2H), 2.99 (t, J = 7.26 Hz, 2H); '^C NMR (CDCI3): ô 168.8, 140.3, 139.8, 136.7, 129.6,
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128.9, 128.2, 128.1, 127.8, 127.5, 125.8, 55.3, 37.5; FTIR: 3057 (m), 3024 (m, aromatic 
C-H), 2945 (m), 2913 (m), 2859 (m, alkane C-H), 1626 (s, C=N) cm '. 
A-(3-Methylbutyl)-4-methoxybenzophenone imine (10): An oven-dried 50-mL round- 
bottomed flask equipped with a magnetic stirring bar and a rubber septum was charged 
with tetrahydrofuran (11 mL) and purged with argon. After cooling to -78 °C, 
n-butyllithium (2.42 M in hexane, 2.37 mL, 5.74 mmol, 1.25 equiv) was added by 
syringe. A solution of A-methyl-4-methoxybenzophenone imine (1.03 g, 4.59 mmol, 
1 equiv) in tetrahydrofuran (10 mL) was transferred dropwise by syringe, over a 
30 minute period. Upon completion of the addition, the red-brown suspension was stirred 
at -78 °C for 1 hr, at 0 °C for 5 min and then cooled to -78 °C. Isobutyl bromide (0.94 g,
6.89 mmol, 1.5 equiv) was added to the reaction flask by syringe and stirring was 
continued at -78 °C for 21 hr. The reddish-brown mixture was warmed to 23 °C and then 
partitioned between dichloromethane ( 6  mL) and water (6  mL). The aqueous layer was 
separated and further extracted with three 6 -mL portions of dichloromethane. The 
combined organic layers were washed with a saturated aqueous sodium chloride solution, 
then dried over anhydrous sodium sulfate and concentrated. The resulting orange oil was 
purified by high-vacuum (50 juTorr) Kugel-Rohr distillation to provide a viscous orange 
oil (1.05 g, 81%). 'H  NMR (CDCI3) (1:1.4 diastereomer ratio, * denotes minor 
diastereomer peaks): ô 7.62-6.77 (m, 9H), 3.87 (s, 3H), 3.81* (s, 3H), 3.42 (t, 
J = 7.05 Hz, 2H), 3.35 (q, J = 7.05 Hz, 2H), 1.69-1.49 (m, IH), 0.84 (d, J = 6.83 Hz, 3H); 
'^C NMR (CDCI3): Ô 168.0, 160.9, 137.3, 129.7, 129.5, 128.3, 128.0, 127.9, 113.3, 55.2, 
40.3, 26.7, 22.8; FTIR: 3056 (m), 2998 (m, aromatic C-H), 2954 (s), 2866 (s, alkane 
C-H), 1603 (s, C=N), 1248 (s), 1036 (m) cm '.
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A-(3-Butenyl)-4-methoxybenzophenone imine (11): The alkylation of A-methyl-4- 
methoxybenzophenone imine (1.38 g, 5.98 mmol, 1 equiv) in tetrahydrofuran (26 mL) 
with allyl bromide (1.09 g, 8.98 mmol, 1.5 equiv) was carried out as described for 10 
(-78 °C for 46 hrs). Purification of the resulting residue by high-vacuum (50 juTorr) 
Kugel-Rohr distillation provided a viscous yellow oil (1.36 g, 8 6 %). *H NMR (CDCI3) 
(1:1.8 diastereomer ratio, * denotes minor diastereomer peaks): ô 7.60-6.73 (m, 9H), 
5.85-4.81 (m, 3H), 3.86 (s, 3H), 3.81* (s, 3H), 3.49 (t, J -  7.05 Hz, 2H), 3.41 (q, 
J = 7.05 Hz, 2H); '^C NMR (CDCI3): 5 167.6, 161.0, 136.9, 132.8, 130.2, 128.4, 128.1,
116.0, 113.7, 113.3, 55.3, 54.1, 53.2, 35.7; FTIR: 3060 (m), 3000 (m, aromatic C-H), 
2954 (s), 2931 (s), 2836 (m, alkane C-H), 1603 (s, C=N), 1249 (s), 1034 (m) cm '. 
A-(2-PhenylethyI)-4-methoxybenzophenone imine (12): The alkylation of A-methyl-4- 
methoxybenzophenone imine (1.96 g, 8.69 mmol, 1 equiv) in tetrahydrofuran (36 mL) 
with benzyl bromide (2.23 g, 13.0 mmol, 1.5 equiv) was carried out as described for 10 
(-78 °C for 19 hrs). Purification of the resulting residue by high-vacuum (50 juTorr) 
Kugel-Rohr distillation provided a viscous yellow oil (2.76 g, 80%). 'H  NMR (CDCI3) 
(1:1.2 diastereomer ratio, * denotes minor diastereomer peaks): ô 7.64-6.79 (m, 14H), 
3.84 (s, 3H), 3.81* (s, 3H), 3.68 (t, J = 7.05 Hz, 2H), 3.61 (t, J = 7.05 Hz, 2H); '^C NMR 
(CDCI3): Ô 168.1, 161.2, 140.3, 132.5, 129.9, 129.7, 129.2, 129.0, 128.4, 128.1, 127.8,
127.6, 125.8, 113.4, 55.2, 37.7; FTIR: 3024 (m, aromatic C-H), 2931 (s, alkane C-H), 
1602 (s, C=N), 1248 (s), 1030 (m) cm '.
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5.3 Imine Substitution and Addition 
A-(2-Oxo-2-phenylethyI)benzophenone imine (13): An oven-dried 25-mL round- 
bottomed flask equipped with a magnetic stirring bar and a rubber septum was charged 
with tetrahydrofuran (10 mL) and purged with argon. After cooling to -78 °C, 
n-butyllithium (2.21 M in hexane, 2.78 mL, 6.15 mmol, 1.20 equiv) was added by 
syringe. A solution of imine 5 (1.06 g, 5.12 mmol, 1 equiv) in tetrahydrofiiran (30 mL) 
was transferred dropwise by syringe, over a 30 minute period. Upon completion of the 
addition, the red-brown suspension was stirred at -78 °C for 1 hr, at 0 °C for 5 min and 
then cooled to -78 °C. Methyl benzoate (0.697 g, 5.12 mmol, 1.0 equiv) was added to the 
reaction flask by syringe and stirring was continued at -78 °C for 6  hr. The reddish- 
brown mixture was warmed to 23 °C and then partitioned between dichloromethane 
(5 mL) and water (5 mL). The aqueous layer was separated and further extracted with 
three 5-mL portions of dichloromethane. The combined organic layers were washed with 
a saturated aqueous sodium chloride solution, then dried over anhydrous sodium sulfate 
and concentrated. The resulting orange oil was purified by flash chromatography (10% 
ethyl acetate in hexane) to provide a viscous yellow oil (l.lOg, 72%). 'H  NMR (CDCI3): 
Ô 8.10 -7.00 (m, 15H), 4.91 (s, 2H).
A-(2-Oxo-3-fluoropropyI)benzophenone imine (14): An oven-dried 25-mL round- 
bottomed flask equipped with a magnetic stirring bar and a rubber septum was charged 
with tetrahydrofuran (10 mL) and purged with argon. After cooling to -78 °C, 
«-butyllithium (2.65 M in hexane, 4.87 mL, 12.9 mmol, 1.25 equiv) was added by 
syringe. A solution of imine 5 (2.02 g, 10.3 mmol, 1 equiv) in tetrahydrofuran (40 mL) 
was transferred dropwise by cannula, over a 30 minute period. Upon completion of the
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addition, the red-brown suspension was stirred at -78 °C for 1 hr, at 0 °C for 5 min and 
then cooled to -78 °C. Ethyl fluoroacetate (1.31 g, 12.4 mmol, 1.2 equiv) was added to 
the reaction flask by syringe and stirring was continued at -78 °C for 10 hr. The orange 
mixture was warmed to 23 °C and then partitioned between dichloromethane (10 mL) 
and water (10 mL). The aqueous layer was separated and further extracted with three 
10-mL portions of dichloromethane. The combined organic layers were washed with a 
saturated aqueous sodium chloride solution, then dried over anhydrous sodium sulfate 
and concentrated. The resulting orange oil was purified by flash chromatography (10% 
ethyl acetate in hexane) to provide a clear yellow oil (1.07g, 41%). 'H  NMR (CDCI3): 8  
7.65 -7.10 (m, lOH), 4.80 (d, Jhf = 47.8 Hz, 2H), 2.52 (dt, Jhf = 3.8 Hz, J = 7.2 Hz, 3H). 
A-(2-HydroxypentyI)benzophenone imine (15): An oven-dried 25-mL round-bottomed 
flask equipped with a magnetic stirring bar and a rubber septum was charged with 
tetrahydrofuran ( 8  mL) and purged with argon. After cooling to -78 °C, «-butyllithium 
(2.50 M in hexane, 1.5 mL, 3.75 mmol, 1.25 equiv) was added by syringe. A solution of 
imine 5 (0.586 g, 3.00 mmol, 1 equiv) in tetrahydrofuran ( 6  mL) was transferred 
dropwise by syringe, over a 30 minute period. Upon completion of the addition, the red- 
brown suspension was stirred at -78 °C for 1 hr, at 0 °C for 5 min and then cooled to 
-78 °C. Butyraldéhyde (0.324 g, 4.50 mmol, 1.5 equiv) was added to the reaction flask 
by syringe and stirring was continued at -78 °C for 16 hrs. The reddish-brown mixture 
was warmed to 23 °C and then partitioned between dichloromethane ( 6  mL) and water ( 6  
mL). The aqueous layer was separated and further extracted with three 6 -mL portions of 
dichloromethane. The combined organic layers were washed with a saturated aqueous 
sodium chloride solution, then dried over anhydrous sodium sulfate and eoneentrated.
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The resulting orange oil was purified by high-vacuum (50 /ixTorr) Kugel-Rohr distillation 
to provide a viscous orange oil (0.635 g, 46%). 'H  NMR (CDCI3): ô 7.82-6.98 (m, lOH),
3.90 (m, IH), 3.43 (m, IH), 3.21 (m, IH), 2.57 (m, IH), 2.38 (m, IH), 1.40 (m, 2H), 0.98 
(t, J = 7.42 Hz, 3H); "C NMR (CDCI3): 6169.3,143.3,130.0,128.9, 128.5, 128.3,128.0,
127.6, 127.2, 126.7, 71.2, 53.8, 20.4, 14.1; FTIR: 3409 (hr, m, OH), 3057 (m, aromatic 
C-H), 2956 (s), 2929 (s), 2869 (s, alkane C-H), 1624 (s, C=N) em '. 
A-(2-HydroxypeiityI)-4-methoxyben2ophenone imine (16): An oven-dried 25-mL 
round-bottomed flask equipped with a magnetic stirring bar and a rubber septum was 
charged with tetrahydrofuran (9 mL) and purged with argon. After cooling to -78 °C, 
«-butyllithium (2.50 M in hexane, 1.78 mL, 4.46 mmol, 1.25 equiv) was added by 
syringe. A solution of A-methyl-4-methoxybenzophenone imine (0.91 g, 3.56 mmol, 
1 equiv) in tetrahydrofuran (7 mL) was transferred dropwise by syringe, over a 30 minute 
period. Upon completion of the addition, the red-brown suspension was stirred at -78 °C 
for 1 hr, at 0 °C for 5 min and then cooled to -78 °C. Butyraldéhyde (0.480 g, 5.35 mmol,
1.5 equiv) was added to the reaction flask by syringe and stirring was continued at -78 °C 
for 15 hr. The reddish-brown mixture was warmed to 23 °C and then partitioned between 
dichloromethane ( 6  mL) and water ( 6  mL). The aqueous layer was separated and further 
extracted with three 6 -mL portions of dichloromethane. The combined organic layers 
were washed with a saturated aqueous sodium chloride solution, then dried over 
anhydrous sodium sulfate and concentrated. The resulting orange oil was purified by 
high-vacuum (50 p,Torr) Kugel-Rohr distillation to provide a viscous orange oil (0.44 g, 
37%) as a mixture of four diastereomers: [£',2(R)], [E,2(S)'\, [Z,2(R)] and [Z,2(5)]; FTIR:
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3056 (m), 3001 (w, aromatic C-H), 2955 (s), 2836 (m, alkane C-H), 1607 (s, C=N), 1253 
(s), 1036 (m) cm '.
A-(2-Hydroxy-3,3-dimethylbutyl)benzophenone imine (17): The alkylation of
A-methylbenzophenone imine (0.781 g, 4.00 mmol, 1 equiv) in tetrahydrofuran (18 mL) 
with trimethylacetaldehyde (0.648 g, 6.00 mmol, 1.5 equiv) was carried out as described 
for 15 (-78 °C for 20 hrs). Purification of the resulting residue by high-vacuum 
(50 fiTorr) Kugel-Rohr distillation provided a viscous yellow oil (1.01 g, 89%). 'H  NMR 
(CDCI3); Ô 7.68-7.07 (m, lOH), 3.58 (t, J = 8.0 Hz, IH), 3.60 (dd, J = 8.0 Hz, 2H), 0.91 
(s, 9H); '^C NMR (CDCI3): 5 167.9, 144.4, 130.1, 129.7, 128.6, 128.1, 127.8, 126.4,
126.0, 125.7, 84.4, 53.9, 26.7; FTIR: 3409 (hr, m, OH), 3059 (m, aromatic C-H), 2954 
(s), 2867 (s, alkane C-H), 1624 (s, C=N),1023 (m, C-O) cm"'.
A-(2-Hydroxy-3,3-dimethyIbutyI)-4-methoxybenzophenone imine (18): The
alkylation of A-methyl-4-methoxybenzophenone imine (1.38 g, 7.09 mmol, 1 equiv) in 
tetrahydrofuran (33 mL) with trimethylacetaldehyde (1.26 g, 10.6 mmol, 1.5 equiv) was 
carried out as described for 16 (-78 °C for 23 hrs). The crude product was isolated as a 
viscous yellow oil (1.79g, 110% crude yield; 84% conversion to product by GC analysis) 
as a mixture of four diastereomers: [E,2(R)], [E,2(5)], [Z,2(R)] and [Z,2(5)]; FTIR: 2953 
(s, aromatic C-H), 2869 (m, alkane C-H), 1609 (s, C=N), 1248 (s), 1034 (m) cm"'. 
(3E')-A-(2-Hydroxy-3-pentenyI)benzophenone imine (19): The alkylation of
A-methylbenzophenone imine (0.390 g, 2.00 mmol, 1 equiv) in tetrahydrofuran (4 mL) 
with crotonaldehyde (0.210 g, 3.00 mmol, 1.5 equiv) was carried out as described for 15 
(-78 °C for 24 hrs). Purification of the resulting residue by high-vacuum 
(50 /iTorr) Kugel-Rohr distillation provided a viscous yellow oil (0.404 g, 76%). 'H
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NMR (CDCI3): ô 7.80-6.98 (m, lOH), 5.90-5.40 (m, 2H), 3.51-2.98 (m, 3H), 1.74-1.40 
(d, J = 7.0 Hz, 3H); FTIR: 3312 (br, m, OH), 3057 (m, aromatic C-H), 2954 (s, alkane 
C-H), 1624 (s, C=N),1027 (m, C-O) cm '; '"C NMR (CDCI3): ô 139.2, 136.9, 131.4,
129.7, 128.5, 128.4, 128.2, 128.0, 127.8, 126.0, 110.6, 72.3, 59.6, 52.3, 17.8. 
A-(2-Hydroxy-2-phenylethyI)benzophenone imine (20): The alkylation of
A-methylbenzophenone imine (0.781 g, 4.00 mmol, 1 equiv) in tetrahydrofuran (4 mL) 
with benzaldehyde (0.637 g, 6.00 mmol, 1.5 equiv) was carried out as described for 15 
(-78 °C for 24 hrs). The crude product was isolated as a viscous yellow oil (1.633 g, 
135% crude yield; 70% conversion to product by 'H  NMR analysis). Recrystallization 
from hexane yielded a white crystalline solid (0.390 g, 32%). 'H  NMR (CDCI3): 8  
7.80-6.78 (m, 15H), 3.63-3.53 (dd, J = 3.6 Hz, IH), 3.52-3.35 (m, 2H).
5.4 Pentenoic Acid Analog Synthesis 
[i5(K),25]-A-(2-Hydroxy-l-methyl-2-phenylethyI)-A-methyl-2-methyl-4- 
pentenamide (21b): Prepared from (75,2<S)-A-(2-hydroxy-l-methyl-2-phenylethyl)-A- 
methylpropionamide (1.00 g, 4.52 mmol, 1 equiv) according to the procedure of Myers^ 
using allyl iodide (1.14 g, 6.78 mmol, 1.50 equiv) in tetrahydrofuran (0.25 M, 0 °C for 
45 min). The product was obtained as a viscous colorless oil (1.13 g, 96%) after 
purification by flash chromatography (25% ethyl acetate in hexane). 'H  NMR (CDCI3) 
(-1:4 rotamer ratio, * denotes minor rotamer peaks, CgDe): 8 7.45-7.30 (m, 2H), 
7.30-7.00 (m, 8 H), 6.00* (m, IH), 5.72 (ddt, J = 17.1, 14.0, 7.0 Hz, IH), 5.25* (d, 
J = 17.0 Hz, IH), 5.12* (d, J = 14.0 Hz, IH), 5.10 (d, J = 17.0 Hz, IH), 5.00 (d, 
J = 14.0 Hz, IH), 4.85* (br, s, IH), 4.60 (dd, J = 7.0 Hz, IH), 4.37 (br, s, IH), 2.92* (s.
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3H), 2.51 (m, IH), 2.36 (m, 2H), 2.34 (m, 3H), 2.09 (m, IH), 1.17* (d, J = 6.7 Hz, 3H), 
1.61 (two superimposed, J = 6.7 Hz, 6 H), 0.78* (d, J = 6 .8  Hz, 3H); '^C NMR (CgDg): ô 
177.4, 176.4*, 143.7, 142.6*, 137.6*, 136.7, 128.6, 127.4, 127.3, 126.8, 116.3, 76.4, 
75.5*, 59.2, 58.1, 38.6, 36.7, 35.9*, 32.9*, 27.1, 17.7*, 17.1, 15.4*, 14.3; FTIR: 3363 (br, 
s, OH), 2974 (s), 1606 (s, C=0), 1451 (s), 1403 (s), 1245 (m), 1022 (m), 914 (s) em '. 
(R>2-MethyI-4-pentenoic acid (22b): Prepared from 21b (5.00 g, 22.6 mmol) according 
to the procedure of Myers.^^ The product was obtained as a colorless oil (1.21 g, 8 8 %). 'H 
NMR (CDCI3): Ô 5.79 (ddt, J = 17.1, 14.0, 7.0 Hz, IH), 5.10 (d, J = 17.0 Hz, IH), 4.95 
(d, J = 14.0 Hz, IH), 2.56 (m, 2H), 2.43 (m, IH), 2.22 (m, IH), 1.20 (d, J = 7.0 Hz, 3H); 
'^C NMR (CDCI3): Ô 182.0, 135.2, 116.9, 39.1, 37.4, 16.2; FTIR: 3400-2600 (br, s), 2982 
(s), 1709 (s, C=0), 1643 (m), 1463 (m), 1418 (m), 1286 (s), 1246 (s), 918 (s) cm '. 
('R>2-Fluoro-2-methyl-4-peiitenal (23): Prepared form [(/5'(Rj,25)]-A-(2-hydroxy-l- 
methyl-2-phenylethyl)-A-methyl-2-fluoro-2-methyl-4-pentenamide^'’ (2.40 g, 8.59 mmol) 
according to the procedure of Myers^. The product was obtained as a colorless oil (1.10 g, 
78%). 'H  NMR (CDCI3): Ô 7.91 (br, s, IH), 5.82 (ddt, J = 17.1, 14.0, 7.0 Hz, IH), 5.22 
(m, 2H), 2.65 (m, 2H), 1.61 (d, Jhf = 21.0 Hz, 3H).
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